Science & Enterprise subscription

Follow us on Twitter

  • This week's report shows a marked increase in activity on therapies, while the number of vaccines in development an… https://t.co/Z7P2ivWaxJ
    about 5 hours ago
  • New post on Science and Enterprise: Covid-19 Vaccines, Therapies – 13 July 2020 https://t.co/epfuGPmjdy #Science #Business
    about 5 hours ago
  • This is nuts. Manufacturing, distribution, and public health infrastructure here are more important than who made t… https://t.co/AOHVdFBlrX
    about 20 hours ago
  • Don't let the perfect be the enemy of the good ... https://t.co/nHtOdudliO
    about 2 days ago
  • Among the tech giants, Apple is the most aggressive in acquiring start-ups developing A.I. applications over the pa… https://t.co/RjpknHBKAR
    about 2 days ago

Please share Science & Enterprise

Engineered Cardiac Tissue Helps Veins Return Blood to Heart

Narine Sarvazyan and lab colleagues

Narine Sarvazyan, foreground, and lab colleagues (lab.sarvazyan.com)

27 March 2014. A pharmacologist at George Washington University in Washington, D.C. developed a technique to produce heart muscle tissue from an individual’s stem cells that helps weak veins return blood back to the heart. The creator of the process, GWU medical school professor Narine Sarvazyan, discussed the technology in a recent online issue of the Journal of Cardiovascular Pharmacology and Therapeutics (paid subscription required).

A provisional patent has been filed for the technology, with Sarvazyan listed as inventor. And the university is already promoting the technology for licensing.

The technique is designed to treat patients with chronic venous insufficiency, a condition where the veins, particularly in the legs are weakened and valves in the veins are not able to pump sufficient blood back to the heart. Symptoms include swelling of legs and ankles, aching or tiredness in the legs, varicose veins, and flaking or itching skin on the legs or feet.

The condition can worsen over time, and lead to ulcers on the skin, which are prone to infection. According to the Cleveland Clinic, some 40 percent of Americans are believed to have some form of chronic venous insufficiency, particularly those over the age of 50.

Sarvazyan’s process creates small pieces of heart muscle that are wrapped like a cuff around the veins of patients with weakened valves. The engineered heart muscle, like natural heart muscle tissue, beats rhythmically, giving a boost to the veins’ ability to direct the blood to the heart. The engineered heart muscle is cultured from the patient’s own stem cells, thus preventing rejection of alien tissue.

Sarvazyan and colleagues from her lab demonstrated the feasibility of the technology in the lab, and further tests are planned with lab animals. The following brief (5 second) lab video shows the engineered heart tissue in operation.

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.